Citius Oncology Inc (CTOR) Price Prediction & ForecastCTORCitius Oncology Inc

Alphio's CTOR stock price prediction model matches the current Citius Oncology Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.76 (-1.49%). The 1-week path is $0.76 (-2.46%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Citius Oncology Inc (CTOR) presents a compelling buy opportunity right now, primarily driven by its recent positive developments in drug commercialization and strong analyst support. The stock is currently priced at $0.78, with a forward P/E ratio of 35.59, indicating potential growth despite current losses. The gross margin for Q1 2026 stands at an impressive 79.99%, suggesting efficient cost management in its operations. However, the main risk lies in the company's significant net loss of $26.61 million reported in Q2 2026, which could impact its financial stability moving forward.

Citius Oncology Inc (CTOR) last closed at $0.7756, losing -1.86%. These facts feed the 1-day and 1-week CTOR price prediction above.